[Therapy and follow-up study of the prostatic neoplasm].
D000230:Adenocarcinoma / Q000473:pathology; D000368:Aged; D001706:Biopsy; D002277:Carcinoma / Q000473:pathology; D002467:Cell Nucleus; D002741:Chlorotrianisene / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D002479:Inclusion Bodies; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011882:Radiotherapy, High-Energy; D013267:Stilbenes / Q000627:therapeutic use; D013737:Testis / Q000601:surgery
D013267:Stilbenes; D004958:Estradiol; D002741:Chlorotrianisene
Therapie des Prostatacarcinoms und Verlaufskontrolle.